«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:

2017年06期

页码:

365-368

栏目:

临床研究

出版日期:

2017-11-25

文章信息/Info

Title:

The expression level of plasma microRNA-126 in patients with coronary atherosclerotic disease and its clinical significance

作者:

吴雪纯; 贾永平

030032 太原,中铁十七局集团中心医院(吴雪纯),030001 太原,山西医科大学第一医院心内科(贾永平)

Author(s):

WU Xuechun¹; JIA Yongping²

1. China Railway 17 Bureau Group Central Hospital 030021; 2. Department of Cardiology, First Hospital of Shanxi Medical Univeristy, Shanxi 030001, China

关键词:

冠状动脉粥样硬化性心脏病;  微小RNA-126;  实时荧光定量聚合酶链式反应

Keywords:

Coronary atherosclerotic disease;  MiRNA-126;  qRT-PCR

分类号:

-

DOI:

10.3969/j.issn.1673-6583.2017.06.012

文献标识码:

A

摘要:

目的:探讨微小RNA(miRNA)-126在冠状动脉粥样硬化性心脏病(冠心病)患者血浆中的表达情况及临床意义。方法:收集2015年2月至2015年6月在山西医科大学第一医院心内科住院的114例冠心病患者(冠心病组)和40例健康者(对照组)的血浆,将冠心病组分为急性心肌梗死组(AMI组,n=40)、不稳定型心绞痛组(UA组,n=38)、稳定型心绞痛组(SA组,n=36)3个亚组,运用实时荧光定量聚合酶链式反应(qRT-PCR)检测各组血浆miRNA-126的表达水平

Abstract:

Objective:To study the difference of microRNA(miR)-126 expression between coronary atherosclerotic heart disease(CAD)patients and healthy people, and discuss its clinical significance.Methods:Collect the plasma of 114 CAD patients(experimental group)hospi

参考文献/References

[1] Bartel DP.MicroRNSs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2):281-297.
[2] Montgomery RL,van Rooij E.Therapeutic advances in MicroRNA targetin[J]. J Cardiovasc Pharmacol, 2011, 57(1):1-7.
[3] Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs[J].Genome Res, 2009, 19(1):92-105.
[4] Takeuchi K, Yanail R, Kumase F, et al. Egf-like-domain-7 is required for vegf-induced akt/erk activation and vascular tube formation in an ex vivo angiogenesis assay[J]. PloS One, 2014, 9(3):e91849.
[5] Ishizaki T, Tamiya T, Taniguchi K, et al.MiR-126 positively regulates mast cell proliferation and cytokine production through suppressing spred1[J]. Genes Cells, 2011, 16(7):803-814.
[6] Wei YY, Nazari M, Neth P, et al. Microrna-126,-145,And-155:a therapeutic triad in atherosclerosis?[J]. Arterioscler Thromb Vasc Biol, 2013, 33(3):449-454.
[7] Giorgio A, Castellano L, Krell J, et al. Crosstalk-induced loss of mir-126 promotes angiogenesis[J]. Oncogene, 2014, 33(28):3634-3635.
[8] Ye P, Liu J, He FY, et al. Hypoxia-induced deregulation of miR-126 and its regulative effect on VEGF and MMP-9 expression[J]. Int J Med, 2013, 11(1):17-23.
[9] Sturgeon CM,Chicha L,Ditadi A,et al.Pitirimve erythropoiesis is regulated by miR-126 via nonhematopoietic Vcam-1⁺cells[J]. Developmental Cell, 2012, 23(1):45-57.
[10] Zhang J, Zhang Z, Zhang DY, et al. microRNA-126 inhibits the transition of endothelial progenitor cells to mesenchymal cells via the PIK3R2-PI3K/Akt signalling pathway[J]. PLoS One, 2013, 8(12):1-9.
[11] Jansen F,Yang X,Hoelscher M,et al.Endothelial microparticle-mediated transfer of microRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles [J]. Circulation, 2013, 128(18):2026-2038.
[12] Small EM, Frast R J, Olson EN. MicroRNAs add a new dimension to cardiovascular disease[J]. Circulatiion, 2010, 12(8):1022-1032.
[13] Zemecke A,Bidzhekov K,Noels H,et al.Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection [J]. Sci Signal, 2009, 2(100):ra81.
[14] Fichtlscherer S,De Rosa S, Fox H,et al.Circulating microRNAs in patients with coronary artery disease[J]. Circ Res, 2010, 107(5):677-684.
[15] Long G,Wang F,Duan Q,et al.Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction[J]. Int J Biol Sci, 2012, 8(6):811-818.

备注/Memo

备注/Memo:

基金项目:山西省科技攻关项目(20140313015-14)
通信作者:贾永平,Email:849782305@qq.com

常用功能

更新日期/Last Update: 2017-12-10